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Abstract
Objective : To obtain the profi le of D-dimer in uncomplicated 
pregnancy.
Methods : A cross sectional study was done on 90 
uncomplicated pregnant women consisted of 30 women 
in each trimester and 30 healthy, nonpregnant women 
as control group from July to August 2012. D-dimer level 
was measured by particle enhanced immunoturbidimetry 
method using Innovance D-dimer and Sysmex CA 1500 in the 
Department of Clinical Pathology, Dr. Cipto Mangunkusumo 
Hospital, Jakarta.
Results : All women in the control group showed normal 
D-dimer level (<0.,5 mg/L FEU). The median and range 
of D-dimer level in the 1st trimester, 2nd trimester, and 3rd 
trimester were 0.42 mg/L FEU and 0.1-1.07 mg/L FEU, 0.97 
mg/L FEU and  0.6-3.34 mg/L FEU, and 1.56 mg/L FEU and 
0.69-3.75 mg/L FEU, respectively.  Increased D-dimer level 
was found in 27% of pregnant women in 1st trimester, 87% 
in 2nd trimester, and 100% in 3rd trimester.
Conclusions : Increased D-dimer level was found in  27% of 
pregnant women in 1st trimester, 87% in 2nd trimester, and 
100% in 3rd trimester. The range of D-dimer level in the 1st 
trimester was 0.1-1.07 mg/L FEU, in the 2nd trimester was 
0.6-3.34 mg/L FEU, and in the 3rd trimester was 0.69-3.75 
mg/L FEU.
Keywords : D-dimer, trimester, uncomplicated pregnancy.
Abstrak
Tujuan : Untuk mendapatkan profi l  D-dimer pada kehamilan 
tanpa komplikasi.
Metode : Penelitian potong lintang dilakukan pada 90 
perempuan hamil tanpa komplikasi yang terdiri atas 30 
perempuan pada tiap trimester dan 30 perempuan sehat 
yang tidak hamil, sebagai kelompok kontrol dari bulan Juli 
sampai Agustus 2012. Kadar D-dimer diukur dengan cara 
particle enhanced immunoturbidimetry menggunakan 
reagen Innovance® D-dimer dan koagulometer Sysmex® 
CA 1500 di  Deparemen Patologi Klinik, Rumah Sakit Umum 
Pusat Nasional Dr. Cipto Mangunkusumo, Jakarta.
Hasil : Seluruh perempuan dalam kelompok kontrol 
mempunyai kadar D-dimer dalam batas normal (<0.,5 
mg/L FEU). Median (rentang) kadar D-dimer pada trimester 
pertama, kedua, dan ketiga berturut-turut  0.42 mg/L FEU 
(0.1-1.07 mg/L FEU), 0.97 mg/L FEU (0.6-3.34 mg/L FEU), 
dan 1.56 mg/L FEU (0.69-3.75 mg/L FEU). Peningkatan kadar 
D-dimer ditemukan pada 27% perempuan hamil trimester 
pertama, 87%  trimester kedua, dan pada 100%  trimester 
ketiga.
Kesimpulan : Peningkatan kadar  D-dimer ditemukan pada 
27% perempuan hamil trimester pertama, 87% trimester 
kedua dan 100% pada trimester ketiga. Rentang kadar 
D-dimer level pada trimester pertama adalah 0.1-1.07 mg/L 
FEU, pada trimester kedua 0.6-3.34 mg/L FEU, dan pada 
trimester ketiga  0.69-3.75 mg/L FEU. 
Kata kunci : D-dimer, kehamilan tanpa komplikasi, 
trimester
INTRODUCTION
The incidence of Venous Thromboembolism 
(VTE) in pregnant women is 4-5 folds higher than 
nonpregnant women.1 Obstetric complications 
that associated with thromboembolisms are 
recurrent abortus, preeclampsia, and fetal growth 
retardation.2 Increased risk of VTE in pregnancy 
is associated with venous stasis due to uterus 
enlargement and hypercoagulable state.1,3 Many 
experts think that hypercoagulable state in 
pregnancy is anaturally occurring mechanism to 
anticipate bleeding during labour.3
The clinical manifestations of VTE are Deep 
Vein Thrombosis (DVT) and Pulmonary Embolism 
(PE).  The accuracy of VTE diagnosis solely based 
on clinical manifestations is low. Venography is 
the gold standard in the diagnosis of DVT, but 
this procedure is invasive, and now compression 
ultrasonography and D-dimer are used as a 
modality in the diagnosis of DVT after clinical 
probability has been determined.4
D-dimer is a degradation product of cross-
linked fi brin by the action of plasmin during 
fi brinolysis process. Since cross-linked fi brin 
is formed as the end  product of   coagulation 
process,   D-dimer can be used as a marker of 
coagulation activation as well as fi brinolysis.5 
Elevated D-dimer level is  found in many  conditions 
where activation of coagulation occurs such as 
VTE, disseminated intravascular coagulation (DIC), 
malignancy, sepsis, postoperative condition, 
post-traumatic injury, myocardial infarction, heart 
failure, liver diseases, pregnancy,  and in elderly. 
Since increased D-dimer is very sensitive but not 
specifi c for VTE, normal level of D-dimer isused 
to exclude the diagnosis of VTE.5
Measurement of D-dimer level in pregnancy 
is vital to predict VTE and associated obstetric 
complications. However, this approach is 
hampered due to increased D dimer in normal 
pregnancy.3 D-dimer level in Caucasian women 
using MDA® Immunoturbidimetric, Organon 
Teknika reported that D-dimer level increased 
above normal value starting from fi rst trimester in 
pregnancy.6 At second trimester normal D-dimer 
level only found in 22% of pregnant women, and 
in the third trimester all pregnant women showed 
increased D-dimer level.6On the other hand who 
measured D-dimer in Nigerian women using 
ELISA technique with Technozym®, Technoclone 
GmDH reported that 63.3% of pregnant women 
had normal D-dimer values (0-200 ng/mL),7 
26.7% of the pregnant women had elevated 
D-dimer values (201-499 ng/mL), while 10.0% 
were found to be at risk of thrombosis (D-dimer 
>500 ng/mL). This discrepancy may be caused by 
different population race and  different   method 
in measuring D dimer. To date, there is no data 
regarding  the D-dimer level in Indonesian 
pregnant women. This situation prompts us 
to determine D-dimer level in Indonesian 
uncomplicated pregnant women in each 
trimester. The objective to study is to obtain the 
profi le of the D-dimer level of uncomplicated 
pregnancy.
METHODS
This study had been approved by the Ethics 
Committee, Faculty of Medicine, Universitas 
Indonesia, Dr. Cipto Mangunkusumo Hospital 
(No.396). Written informed consents were 
obtained from all subjects. This study was 
designed as a cross-sectional study and was 
performed from July to August 2012.
Subject and Control
Based on  results, the minimum number of 
subjects in each trimester was 29 6. In this study 
30 subjects in each trimester wererecruited from 
the Obstetric clinic in Dr. Cipto Mangunkusumo 
Hospital, and from several Community Health 
Centres in Matraman, Jatinegara, Cakung, and 
Pulogadung. Inclusion criteria were pregnant 
women on the fi rst, second, and third trimester. 
Control group were 30 healthy, nonpregnant 
women of the same reproductive age that 
were recruited from students and laboratory 
technician. Exclusion criteria were hypertension, 
leg oedema, seizures, leukocyte count more than 
12 000/mL, proteinuria, and diabetes mellitus. 
Additional exclusion criteria for the control group 
were positive in pregnancy test, infl ammation, 
and oral contraceptive users. Samples collection 
were done consecutively.
Samples and Measurement
Samples for this study comprised blood and 
urine. Blood was collected by veni puncture 
at fossa cubiti, 3 mL of blood was mixed with 
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trisodium citrate 0.109 M as an anticoagulant 
for D-dimer determination and 3 mL was mixed 
with K3EDTA for hematology examination. Citrate 
bloodwas centrifuged at 1500 x g for 15 minutes 
to obtain platelet-poor plasma for D-dimer 
measurement. Hematology examination was 
done using hematology analyzer Sysmex XE-
2100. Proteinuria and glucosuria were examined 
by semi quantitative method using AIM URI-
TEST®according to manufacturer instruction.
Determination of D-dimer Level
Determination of D-dimer level was performed 
using Innovance® D dimer Kit, Sysmex  consisted 
of Innovance D-dimer Reagent which contains 
polystyrene particle coated with monoclonal 
mouse antibodies against D-dimer, Innovance 
D-dimer Buffer is buffer saline solution which 
contains detergent and carbohydrate polymer, 
Innovance D-dimer Supplement is buffer saline 
solution which contains blocking reagent to 
inhibit nonspecifi c reaction against heterophilic 
antibodies such as rheumatoid factor and anti-
mouse antibody, Innovance D-dimer Diluent is 
buffer saline solution which contains detergent to 
dilute sample, control, and calibrator. Principle of 
Innovance® D-dimer assay is particle-enhanced 
immunoturbidimetric assay. D-dimer in the plasma 
reacted with specifi c monoclonal antibody-coated 
bead and resulted in agglutination and increased 
turbidity. Increased turbidity was measured by 
Sysmex CA1500.8,9 Before measuring D-dimer 
in plasma samples, precision and accuracy tests 
were done by measuring Innovance® D-dimer 
control 1 (normal control) with assign value 0.26 
– 0.38mg/L FEU and Innovance® D dimer control 
2 (abnormal control) with assign value 2.22 – 3.32 
mg/L FEU.
Statistical Analysis
The result of precision test was analyzed by 
calculating the mean, standard deviation and 
Coeffi cient of Variation (CV). Accuracy was 
analyzed by calculating the difference between 
the smallest and largest value obtainedfrom the 
target value.
Data analyses of D-dimer of pregnant and 
control groups were done based on data 
distribution. Distribution of continuous data was 
analyzed.10Data with normal distribution would 
be presented as mean and standard deviation, 
while data with abnormal distribution would be 
presented as median and range. The difference 
between groupswith normal distribution was 
analyzed by one way ANOVA. If there was a 
signifi cant difference, ANOVA was followed by 
Post-Hoc analysis. If abnormal distribution was 
obtained, logarithmic transformation should be 
done and the distribution oftransformed data 
would be checked. If data distribution was still 
abnormal, then analysis was used to analyze the 
difference between groups.11 Statistical analyses 
were done using SPSS version 12.
RESULTS
The results of within run precision test using 
Innovance® D-dimer normal control and 
abnormal control revealed CV 2.5% and 1.36%, 
respectively. While the results of accuracy test 
revealed d=(-12,5%) – (-6.2%) for normal control 
and d= (-0.9%) – (5.0%) for abnormal control. 
Data distribution of D-dimer in the pregnant 
group as well as in control group were abnormal; 
thus, data were presented as median and range 
from minimum to maximum (Table 1).
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Table 1. The Level of D-dimer in Pregnant Women and 
Control Group
Group Median
(mg/L FEU)
Control
1st trimester
2nd trimester
3rd trimester
0.21
0.42
0.97
1.56
0.11 – 0.50
0.17 – 1.07
0.31 – 3.34
0.69 – 3.75
30
30
30
30
Range (min-max)
(mg/L FEU)
n
Figure 1. Boxplot of D-dimer Level in Pregnant Women and 
Control Group
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Based on 0.5 mg/L Fibrinogen Equivalent Unit 
(FEU)as the upper limit of normal range, increased 
D-dimer level was found in 8 out of 30 (27%) 
pregnant women  in fi rst trimester, 26 out of 30 
(87%) pregnant women in second trimester, and 
all (100%) pregnant women in third trimester 
(Table 2). There was nosubject who showed 
increased D-dimer level in the control group.
After logarithmic transformation, it was found 
that datadistribution of D-dimer in all trimester 
was normal. The result of one way ANOVA 
revealed that p = 0.00, so Post-Hoc analysis was 
done. Post-Hoc analysis between the control 
group, fi rst trimester, second trimester, and third 
trimester revealed p=0.00.
Table 2. The Proportion of Women with Increased D-dimer 
Level
Group
Control group
1st trimester 
2nd trimester
3rd trimester
0
27
87
100
Proportion of subjects with
increased D-dimer level (%)
Table 3. Comparison of the Results of This Study with Data from the References 
Author 
Country
Method Reagent 1st trimester
mg/L or μg/mL
2nd trimester
mg/L or μg/mL
3rd trimester
mg/L or μg/mL
Cut 
off
Kline6 et al
US
Kawaguchi11 et al
Japan
Reger12 et al
Hungary
Hedengran13 et al
Denmark
Elst5 et al
Belgium
Morse14 et al
UK
This Study Indonesia
*mean±SD, ** median (range)
Immunoturbidimetric
Latex agglutination
Not mentioned
Latex agglutination
ELFA
Not mentioned
Immunoturbidimetric
0.58±0.36*
0.82±0.79*
0.250 (0.152-0.607)**
0.2–0.9
0.18–0.30
0.191±0.025*
0.42(0.17 – 1.07)**
0.83±0.46*
1.78±1.67*
0.309(0.191-0.874)**
0.2–1.5
0.18-1.29
0.393±0.072*
0.97(0.31 – 3.34)**
1.16±0.57*
2.48±2.36*
0.541(0.260-1.036)**
0.4--2.8
0.28-2.08
0.544±0.096*
1.56(0.69 – 3.75)**
MDA
Mitsubishi Kagaku 
Iatron Inc, Tokyo
IL, Milano
STA Liatest D-DI
Vidas,
Biomerieux
IL- TestTM D dimer
Innovance, Sysmex
0.5
1.0
0.250
0.5
0.5
0.280
0.5
DISCUSSION
The results of within run precision using normal 
and abnormal control revealed CV=2.5% and 
1.36%, respectively. These values were still 
lower than allowable CV mentioned by the 
manufacturer, i.e.:  4.1% for normal control and 
1.4% for abnormal control. 
The results of accuracy test indicated d=(-12.5%) 
- (-6.2%) using normal control and d=(-0.9%) - 
(5.0%) using abnormal control. Both values were 
still lower than allowable value mentioned by 
manufacturer 18.75% for normal control and 
19.85% for abnormal control. Based on precision 
and accuracy, Ddimer measurement in this study 
is valid.
The level of D dimer in the control group 
showed that median was 0.21 mg/L FEU with 
range 0.11 – 0.50 mg/LFEU. Increased D dimer 
level was not found in the control group. In 
pregnant women median and range of D dimer 
level in the fi rst, second, and third trimester were 
0.42(0.17– 1.07)mg/L FEU, 0.97(0.31 – 3.34) mg/L 
FEU, and 1.56(0.69 -3.75)mg/L FEU,respectively.
Comparisonof the results of this study with data 
from the literature presented in table 3.
It was shown that the increased D dimer level 
during pregnancy was obtained by other studies.
The difference of D dimer level in pregnancy, as 
shown in table 3 might be caused bydifferent 
method,  reagent, cutoff value,  and population. 
The study who measured D- dimer level in 
the same samples of pregnant women using 
5 different reagents confi rmed that different 
reagents and methods caused variability of 
D-dimer level (Table 4).15
Table 4. Median and Range of D-dimer Level at Pregnancy Determined by Various Methods15
Reagents (unit)
Vidas®
(μg/mL FEU)
Asserachrome®
(μg/mL FEU)
Dimertest®
(μg/mL FEU)
Liatest®
(μg/mL FEU)
Innovance D-dimer
(μg/mL FEU)
ELFA
MicroELISA
Latex agglutination
Latex agglutination
Immunoturbidimetry
0.6
(0.15 – 1.35)
0.65
(0.19 – 1.17)
0.27
(0.21 – 0.34)
0.48
(0.22 – 1.06)
0.80
(0.21- 1.51)
0.71
(0.55 – 0.95)
0.66
(0.51 – 0.89)
0.42
(0.29 – 0.70)
0.52
(0.33 – 0.82)
0.93
(0.74 – 1.17)
1.48
(0.97 – 2.05)
1.25
(0.84 - 2.19)
0.82
(0.47 – 1.04)
0.99
(0.67 – 1.77)
1.56
(1.10 – 2.67)
1st trimester 2nd trimester 3rd trimesterMethod
The results of our study in the second and third 
trimester as shown in table 3 were similar with 
the result when using Innovance D-dimer (the 
same reagents that were used in this study).This 
indicated that D dimer level was not affected by 
population race.15 
Many studies reported that D-dimer level 
increased during pregnancy, some studies 
revealed that increased D-dimer was started at 
the fi rst trimester, but the others started at the 
second trimester. In our study increased D-dimer 
level was found in 27% of pregnant women in the 
fi rst trimester, 87% in the second trimester and 
100% in the 3rd trimester. It means that activation 
of coagulation started from the fi rst trimester 
of pregnancy and was progressively increased. 
This result that increased D-dimer was started in 
the fi rst trimester, found in 78% in the second 
trimester and all pregnant women in the third 
trimester.6 Increased D-dimer was found in 21.2% 
in gestational week 4-13, 59.4% in gestational 
week 14-27, 85.2% in gestational week  28-35, 
and 92.3% in gestational week 36-42.11  On the 
other hand, reported that increased D dimer was 
found in more than 25% of pregnant women in 
gestational week 13-20, and by weeks 36-42, all 
of the pregnant women had D-dimer level above 
threshold.13
This discrepancy may be caused by different 
specifi city of D-dimer reagent and different unit 
in expressing the result. The performance of 
each D-dimer reagent differs, depending on the 
specifi city of the monoclonal antibodies used in 
the kit, variability in the cutoff value to identify 
positive results, and heterogeneity of the patient 
population16. Monoclonal antibodies used in 
the kit recognize neoepitopes on D-dimer that 
are not expressed on D domains of non-cross-
linked fi brin. In addition, up to now, there is no 
international standard as a reference in measuring 
D-dimer level.
The result of our study indicated that 
coagulation cascade had been activated since the 
fi rst trimester. This condition might be caused by 
thromboplastin substances released by placenta, 
which trigger coagulation cascade by activating 
factor VII.17As reported by many authors, changes 
in the balance of coagulation and fi brinolysis 
occur in pregnancy.1,17,18 Increased level of some 
coagulation factors such as fi brinogen, factor VII, 
VIII, X, and von Willebrand factor, and reduced 
protein S, a natural anticoagulant, result in 
hypercoagulability in pregnancy.1,17 In addition, 
fi brinolytic activity is depressed in pregnancy 
due to increased plasminogen activator inhibitor 
1 and plasminogen activator inhibitor 2.1,17,18All of 
these changes cause an imbalance of hemostasis, 
which favours to thrombotic tendency.
In many studies, all pregnant women in the third 
trimester showed increased D-dimer level and 
the highest D-dimer level was found in the third 
trimester. It means that activation of coagulation 
reached the peak at the third trimester.
The impact of this study is the upper limit 
of the normal range of 0.5 mg/L FEU cannot be 
used as a cutoff value to rule out thrombosis in 
pregnancy. It is recommended to determinea 
new cutoff value of D dimer in pregnancy that 
can be used to exclude VTE.
The strength of this study is the fi rst study 
in Indonesia which determine D dimer level 
in pregnancy while the weakness of the study 
measures D dimer only performed using 1 
reagent while there are many reagents available 
in the market in Indonesia.
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CONCLUSION
Increased D-dimer level in pregnant women was 
started in the fi rst trimester, and it was found in 
27% of pregnant women in the fi rst trimester, 
87%in the second trimester, and in 100% in the 
third trimester. To exclude VTE in pregnancy, 
determination of a new cutoff value of D-dimer is 
recommended.
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